As cases of metabolic liver disease rise globally, new research shows the condition significantly increases atrial fibrillation risk, even more than moderate alcohol intake, prompting calls for broader cardiovascular monitoring.
Review of hospital records revealed increased risks of malignant tumors, periodontal disease, apical periodontitis, and periapical cysts among patients with diabetes compared with those without.
Frailty screening emerges as a critical consideration in PRISm patients as new findings reveal overlapping systemic vulnerabilities with COPD, despite preserved lung function ratio.
Accelerated approval granted to Wegovy for treatment of noncirrhotic metabolic dysfunction–associated steatohepatitis in adults with stage F2 to F3 fibrosis.